Abstract: The invention relates to a rotor device for a peristaltic pump comprising a housing, a supporting shaft extending in an axial direction and being mounted in the housing, a rotor comprising a rotor-body mounted on the supporting shaft and extending in a radial direction from the supporting shaft and a plurality of rollers, mounted on the radially outer portion of the rotor-body and a driving device connected to the supporting shaft for driving the rotor, wherein the peristaltic pump further comprises a number of roller-markers corresponding to the number of rollers, wherein the roller-markers indicate a dead zone, the roller-markers are provided directly or indirectly on the supporting shaft.
Type:
Application
Filed:
June 25, 2015
Publication date:
July 27, 2017
Applicant:
Merck Patent GmbH
Inventors:
Raoul WEIL, Emmanuelle SIMON, Christophe DI-PALO, Vincent SCHAAL
Abstract: The present invention relates to colored effect pigments, in particular to those containing an organic color pigment layer, to a preparation method thereof and to the use of these pigments especially in a composition comprising the colored effect pigments.
Abstract: The present invention relates compounds comprising a tetra-heteroaryl indacenodithiophene-based structural unit, the synthesis of such compounds as well as their use in organic electronic devices. The invention further relates to organic electronic devices comprising such compounds.
Type:
Application
Filed:
June 26, 2015
Publication date:
July 27, 2017
Applicant:
Merck Patent GmbH
Inventors:
William MITCHELL, Mansoor D'LAVARI, Changsheng WANG, David SPARROWE
Abstract: The invention relates to a layer or article comprising cholesteric liquid crystal polymer particles, which are optionally dispersed in a continuous phase, to cholesteric polymer particles for use in such a layer or article, to methods of preparing such a layer or article, and to the use of such a layer or article as optical element, in windows or electrooptical devices like liquid crystal displays (LCDs).
Type:
Grant
Filed:
March 19, 2014
Date of Patent:
July 25, 2017
Assignee:
MERCK PATENT GMBH
Inventors:
Eduardo Beltran Gracia, Owain Llyr Parri
Abstract: The invention relates to a liquid-crystalline medium based on a mixture of polar compounds which contains at least one compound of the formula I, and at least one additional compound, and to the use of the LC mixtures for an active- or passive matrix addressed displays, in particular based on the VA, PSA, PS-VA, IPS, FFS, PS-IPS, PS-FFS technology, preferably in optical displays for the self-aligning VA mode.
Abstract: The present invention relates to liquid-crystalline media comprising one or more chiral compounds and one or more compounds selected from the group of compounds of formulae I, II and III, in which the parameters have the meaning indicated in Claim 1, and to components comprising these media for high-frequency technology, in particular phase shifters and microwave array antennas.
Abstract: The present invention relates to compounds of the formula (I) and to the use thereof in organic electronic devices, and to organic electronic devices which comprise compounds of the formula (I), preferably as hole-transport materials and/or as matrix materials, in particular in combination with a further matrix material.
Type:
Grant
Filed:
July 31, 2015
Date of Patent:
July 18, 2017
Assignee:
Merck Patent GmbH
Inventors:
Amir H. Parham, Christof Pflumm, Constanze Brocke
Abstract: The present invention relates to novel spiro-quinazolinone derivatives as positive allosteric modulators for modulating metabotropic glutamate receptor subtype 4 (mGluR4) and/or altering glutamate level or glutamatergic signalling.
Type:
Grant
Filed:
January 23, 2014
Date of Patent:
July 18, 2017
Assignee:
MERCK PATENT GMBH
Inventors:
Nadia Brugger, Brian L. Hodous, Amanda E. Sutton, Justin Potnick, Theresa L. Johnson, Thomas E. Richardson, Thomas Francis Nelson Haxell, James M. Dorsey, Robert James Foglesong
Abstract: The application relates to a liquid-crystalline medium comprising at least one dichroic dye having a rylene structure which absorbs red light. The application furthermore relates to a device, preferably a device for the regulation of the passage of energy through a light-transmitting area, which contains the liquid-crystalline medium.
Type:
Grant
Filed:
November 22, 2013
Date of Patent:
July 11, 2017
Assignee:
Merck Patent GmbH
Inventors:
Michael Junge, Andreas Beyer, Ursula Patwal, Peer Kirsch, Susann Beck, Casper Laurens Van Oosten, Felix Fritz Rudolf Schlosser
Abstract: The invention relates to a compound of formula I wherein R1, R2 and R3 are identical or different and each is H or alkyl of 1-6 carbon atoms, R4 is H or methyl, R5 is phenyl or chlorophenyl, and/or physiologically acceptable salts thereof and its use in compositions, especially topical, cosmetic and/or personal care compositions, and compositions containing said compound.
Type:
Grant
Filed:
October 22, 2012
Date of Patent:
July 11, 2017
Assignee:
Merck Patent GmbH
Inventors:
Soheila Anzali, Francis Contard, Jean Jacques Zeiller
Abstract: The present invention relates to a liquid-crystalline medium based on a mixture of polar compounds having negative dielectric anisotropy (??), which is distinguished by the fact that it has a value for the ratio ?1/?n2 in the range 6-45 with a clearing point of >60° C. and a ?? of ??2.3. Media of this type are particularly suitable for electro-optical displays having active-matrix addressing based on the ECB, PA LCD, FFS or IPS effect.
Abstract: The invention relates to a pharmaceutical composition comprising as active ingredient an effective amount of 2-Methyl-4,5-di-(methylsulfonyl)-benzoyl-guanidine, or derivatives thereof, for the prophylaxis and therapy of Type II diabetes mellitus, the Metabolic syndrome, diabetic nephropathy and/or neuropathy. Another object of the invention concerns the use of 2-Methyl-4,5-di-(methylsulfonyl)-benzoyl-guanidine, or derivatives thereof, for the enhancement of insulin sensitivity and the preservation or increase of ?-cell compensation.
Type:
Application
Filed:
March 24, 2017
Publication date:
July 6, 2017
Applicant:
Merck Patent GmbH
Inventors:
Norbert BEIER, Wolfgang SCHOLZ, Ulrich BETZ, Marian BRAENDLE
Abstract: The present invention relates to a Tabletting aid with a low water content and to a process for the preparation thereof. The Tabletting aid composition is a directly compressible composition, the use of which results in improved tablet properties.
Type:
Application
Filed:
March 22, 2017
Publication date:
July 6, 2017
Applicant:
Merck Patent GmbH
Inventors:
James EASSON, Walter HAMM, Guenter MODDELMOG
Abstract: The invention relates to mesogenic media comprising one or more bimesogenic compounds, one or more nematogenic compound, one or more chiral compound and a compound of formula I, R11-A11-(Z12-A12)m-AG??I in which, the parameter A11, A12, Z12 and R11 have one of the meanings as given in claim 1, and to the use of these mesogenic media in liquid crystal devices and in particular in flexoelectric liquid crystal devices, as well as to liquid crystal devices comprising a liquid crystal medium according to the present invention.
Type:
Application
Filed:
June 15, 2015
Publication date:
July 6, 2017
Applicant:
MERCK PATENT GMBH
Inventors:
Owain Ilyr PARRI, Graziano ARCHETTI, Simon SIEMIANOWSKI, Izumi SAITO, Rachel TUFFIN
Abstract: The present invention relates to polymers containing 2,7-pyrene structural units, to a process for the preparation thereof, and to blends and formulations comprising these polymers. The present invention furthermore relates to the use of the polymers or blends according to the invention in electronic devices and to electronic devices, in particular OLEDs, comprising the polymers or blends according to the invention.
Abstract: The present invention relates to a formulation with which electronic devices can be produced with improved performance with respect to operating voltage, efficiency and service life. The present invention likewise relates to a method for producing a formulation according to the invention and to a method for producing electronic devices using the formulation according to the invention. Furthermore, the present invention also relates to an electronic device that has been produced using the method according to the invention.
Type:
Grant
Filed:
October 30, 2013
Date of Patent:
July 4, 2017
Assignee:
Merck Patent GmbH
Inventors:
Herwig Buchholz, Thomas Eberle, Junyou Pan
Abstract: A biocidal fluid purification cap (2) for a fluid container (1), preferably one storing purified water for use in laboratory environments and especially purified water for cell culture and water for molecular biology. The purification cap (2) includes a cap body (3) including an engagement feature (20) for removably attaching the cap body (3) to a mating engagement feature on a spout of the fluid container (1) to hermetically close a spout opening, at least one LED (7a) adapted to emit light in the UV-C range, electronic circuitry (15) for driving the LED(s) (7a), and a power supply for the electronic circuitry (15). The LED(s) (7a) is/are arranged in said cap body (3) so as to be separated from the environment by an UV-transparent window (6) provided in the cap body (3) such that light emitted from said LED(s) (7a) enters the opening of the spout when the cap (2) is attached to the spout of the container (1).
Abstract: The invention relates to novel conjugated polymers containing one or more thieno[3,2-b]thiophene based polycyclic repeating units, to methods for their preparation and educts or intermediates used therein, to polymer blends, mixtures and formulations containing them, to the use of the polymers, polymer blends, mixtures and formulations as organic semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising these polymers, polymer blends, mixtures or formulations.
Type:
Grant
Filed:
June 4, 2013
Date of Patent:
July 4, 2017
Assignee:
MERCK PATENT GMBH
Inventors:
William Mitchell, Mansoor D'Lavari, Changsheng Wang, Steven Tierney, David Sparrowe